497
Êßæíä ÈáÇØÉ ãÇÕÉ ááÕæÊ acoustical tile ãÕäæÚÉ ãä ÇáÌÈÓ gypsum / ÃáíÇÝ ÓíáæáæÒíÉ cellulosic fiber
498
ÓÏÇÏÉ ÛíÑ ãÈØäÉ ááÃæÚíÉ
499
ÚãáíÉ áÊÍÖíÑ ÇæáíÝíäÇÊ olefins ÎÝíÝÉ ÈÅÒÇáÉ åíÏÑæÌíä dehydrogenation ÇáÈÇÑÇÝíäÇÊ paraffins ÇáãÊäÇÙÑÉ
500
ÊÑßíÈÇÊ ÕíÏáíÉ ãÊæÇÒäÉ ÇÓÇÓåÇ ßíäæÈÑíÓÊíä quinupristine æÏÇáÝæÈÑíÓÊíä dalfopristine æÊÍÖíÑåÇ
501
ãÍÇÞä
502
ÚÏøóÇÏ ãíßÇ***í áÌåÇÒ ÞíÇÓ Metering Apparatus
503
ÍáÞÇÊ ãÎáØÉ ËäÇÆíÉ ÇáÍáÞÉ ÊÍãá ÈÏíáíä ¡ ØÑíÞÉ ÊÍÖíÑåÇ æÇÓÊÎÏÇãåÇ ÈÕÝÊåÇ ÊÑÇßíÈ ÕíÏáíÉ
504
ÚãáíÉ áÈáãÑÉ ÇáÃæáíÝíäÇÊ ÈÅÓÊÎÏÇã ÃäÙãÉ ÍÝÇÒ ãä äæÚ Ziegler-Natta
505
ÊÔÛíá ÇáÛÇÒÇÊ ÇáÛäíÉ ÈÇáäíÊÑæÌíä nitrogen æÇáåíÏÑæÌíä hydrogen æÇáÛÇÒÇÊ ÇáÛäíÉ ÈÇáÃæáíÝíä olefin ãÚ ÇáãÐíÈÇÊ ÇáÝíÒíÇÆíÉ
506
ãÔÊÞÇÊ ÈíÑíãíÏíä pyrimidine derivatives æÚãáíÇÊ Ýí ÇÚÏÇÏåÇ
507
åíÏÑÇÒæäÜÇÊ hydrazones
508
ØÑíÞÉ áãÚÇáÌÉ ÇáÕáÚ ÇáÃäÏÑæÌíäí androgenic alopecia ÈæÇÓØÉ ãËÈØÇÊ ÅäÒíã 5- ÃáÝÇ ÑÏÇßÊÇÒ 5–alpha reductase inhibitors
509
ÊÑßíÈÇÊ ÍÝÇÒ ÊÍÊæí Úáì ÒíæáíÊ ÈíÊÇ zeolite-beta æÇÓÊÎÏÇãåÇ Ýí ÚãáíÇÊ ÊÍæíá åíÏÑæßÑÈæä áÇäÊÇÌ ãæÇÏ ãäÎÝÖÉ ÏÑÌÉ ÇáÛáíÇä.
510
ØÑíÞÉ áÊÍÖíÑ 3¡1- ÇáßÜÇä ÏíæáÇÊ æ3- åíÏÑæßÓí ÇáÏåíÏÇÊ 1,3-Alkanediols and 3-hydroxyaldehydes
511
ÓãÇÚÉ äÞá ÇáÕæÊ ãä ÇáåæÇÊÝ ÇáÌæÇáÉ
512
ÌÑÓ ÅäÐÇÑ ãÇÆí
513
ÑÈÇÚí åíÏÑæßÑÈÇÒæá Teterahydrocarbazole ßÚæÇãá ãÓÇÚÏÉ áãÓÊÞÈá 5HT1
514
ÕæÑ áÌÑÚÇÊ ÕíÏáÇäíÉ ÊÚØì Úä ØÑíÞ ÇáÝã æÊÔÊãá Úáì ãËÈØ áãÖÎÉ ÇáÈÑæÊæä proton pump æ NASID
515
ÚãáíÉ áÊÍÖíÑ ßÍæáÇÊ ãÊÚÏÏÉ ÇáÊßÇÝÄ polyvalent alcohols
516
ÇÓÊÎÏÇã ÊæáíÝÉ ãä ãËÈØÇÊ ÅäÒíã K+ - ATPase¡ H+ æÌáæßæßæÑÊíßæíÏÇÊ glucocorticoids Ýí ÚáÇÌ ÇáÓøóáíáÇÊ ÇáÃäÝíÉ nasal polyps
517
ãÔÊÞÇÊ ÍãÖ N - ÃÓíÊíá äíÑÇãí*** N-Acetyl Neuraminic ÇáãÈáæÑ æØÑíÞÉ ÊÍÖíÑåÇ
518
ØÑíÞÉ ãäÎÝÖÉ ÇáÖÛØ ÛíÑ ãÈÑÏÉ áÇÓÊÎáÇÕ ÇáÇíËíáíä
519
ØÑíÞÉ áÊÍÖíÑ åíÏÑæßáæÑíÏ áíÑßÇäíÏíÈíä lercanidipinehydrochloride
520
ÊÑßíÈÇÊ áÊËÈíØ inhibiting ÊÌãÚ ÇáÕÝÇÆÍ ÇáÏãæíÉ plateletaggregation
521
ãÓÊÍÖÑÇÊ ÏæÇÆíÉ ãÔÊãáÉ Úáì ÝæÑíßæäÇÒæá voriconazole
522
ØÑíÞÉ áÝÕá ÇáÈÇÑÇÒíáíä paraxylene ÊÔÊãá Úáì ãÑÍáÉ ÊÈáæÑ æÇÍÏÉ Úáì ÇáÃÞá Ýí ÏÑÌÉ ÍÑÇÑÉ ãÑÊÝÚÉ æãÚÇáÌÉ ØÝáíÉ clay treatment æÇÍÏÉ Úáì ÇáÃÞá ÞÈá ãäØÞÉ ÇáÅãÊÒÇÒAdsorption zone
523
ãÇÏÉ ÍÝÇÒÉ ãä ÇáÈáÇÏíæã ÇáÐåÈ gold - palladium áÅäÊÇÌ ÃÓíÊÇÊ ÇáÝíäíá vinyl acetate
524
ÊÑßíÈÉ áÞÇÍ ÊÍÊæí Úáì ãæÇÏ ãÓÇÚÏÉ ááãäÇÚÉ adjuvants
525
ãÍÝÒ ÈáÇÏíæã- ÐåÈpalladium-gold ËäÇÆí ÇáãÚÏä ãÊÛÇíÑ ÇáÎæÇÕheterogeneous bi****llic áÅäÊÇÌ ÃÓíÊÇÊ Ýíäíávinyl acetate
526
ãÑßÈÇÊ ÕíÏáÇäíÉ
527
ãÑßÈ tricyclic ]pyridi- nesa5,6-dihydro-9H-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-
528
áÇßÊÇãÇÊ æÅíãíÏÇÊ ÍáÞíÉ ãÛÇíÑÉ ÃÑÇáßíá æÃÑÇáßíáíÏíä aralkyland aralkylidene heterocyclic lactams and imides
529
ÇáãÑßÈÇÊ ÇáãÊÖãäÉ ÃãáÇÍ ÃÑíá- ÍáÞíÉ ãÛÇíÑÉ aryl-heterocyclic
530
ÍÝÇÒÇÊ ÊÍÊæí Úáì äÓÈÉ ÚÇáíÉ ãä ÇáÝÖÉ silver áÅäÊÇÌ ÃßÓíÏ Çáßíáíäalkylene oxide
531
ãÑßÈÇÊ ãÝíÏÉ áÚáÇÌ ÃãÑÇÖ ÇáÍÓÇÓíÉ æÇáÃãÑÇÖ ÇáÇáÊåÇÈíÉ
532
ãÑßÈÇÊ ßæíäæáíä quinoline æßæíäÇÒæáíä quinazoline ãÝíÏÉ Ýí ÇáÚáÇÌ¡ ÈÇáÊÍÏíÏ Ýí ÚáÇÌ ÊÖÎã ÇáÈÑæÓÊÇÊÇ ÇáÍãíÏ
533
ØÈÞÉ ÎÇÑÌíÉ áÚäÕÑ ÃäÈæÈí æØÑíÞÉ ÚãáåÇ
534
ÊÜÑÇßíÜÈ ÓÜÇÆáÉ ÓÜÑíÚÉ ÇáÇãÊÕÜÇÕ rapidly absorbed
535
ÃäÇÈíÈ ãÔÞæÞÉ ááãÈÇÏáÇÊ ÇáÍÑÇÑíÉ Ýí ÃÌåÒÉ ÊßííÝ ÇáåæÇÁ æÃÌåÒÉ ÇáÊÈÑíÏ æÇáãÈÇÏáÇÊ ÇáãäÇÙÑÉ
536
ÌåÇÒ æØÑíÞÉ áÎáØ ãáÇØ mortar íÍÊæí Úáì äÓÈÉ ãÚíäÉ ãä ÇáÑãá æÇáÃÓãäÊ æÇáãÇÁ
537
ÚãáíÉ áÈáãÑÉ ãæäæãÑÇÊmonomers Ýí ØÈÞÇÊ ããíÚÉfluidizedbeds
538
ÚãáíÉ áÅÚÇÏÉ ÊæáíÏ ãæÇÏ ÍÝÇÒÉ ãä äæÚ ÓáíßÇáÇíÊ ÇáÊíÊÇäíæã
539
ÇÓÊÎáÇÕ ÍãÖ ÇáÎáíß acetic acid ãä ÊíÇÑÇÊ ãÇÆíÉ ãÎÝÝÉ ãÊÔßáÉ ÃËäÇÁÚãáíÉ ßÑÈæäíáíÉ arbonylation process
540
ÚÈæÉ ÊÓÊÎÏã ááÊÔÑíÈ infusion æØÑíÞÉ ÊÕäíÚåÇ
541
ãËÈØÇÊ ãÇÏÉ ÇáãíÊÇáæÈÑæÊíÇÒ
542
ãÑßÈÇÊ ÕíÏáíÉ
543
ÚãáíÉ ÅÚÇÏÉ ÊæáíÏ ÎÇÑÌ ÇáãæÞÚ áãÇÏÉ ÍÝÇÒÉ ÊÍÊæí Úáì ÇáÇÞá Úáì ãÚÏä ßÑíã æÇÍÏ.
544
ãÝÇÚá ááÊÍæíá ÇáÍÑÇÑí ÇáÐÇÊí ááåíÏÑæßÑÈæäÇÊ hydrocarbons
545
ÚáÈÉ ÕÛíÑÉ canisterÊÔÊãá Úáì ÊÑßíÈÉ ãä ãÞæã ÝÚøÇá æÛÇÒ ÏÇÓÑ propellant íÊßæä ãä ÝáæÑæ åíÏÑæßÑÈæä fluorohydrocarbon
546
ÎÒÇä tank áÊÎÒíä ãäÊÌÇÊ ÓÇÆáÉ
01-14-2008, 06:45 PM
